US EditionCanadian health officials warn against counterfeit versions of Ozempic, Mounjaro
Health Canada warns counterfeit GLP-1 drugs sold nationwide may contain dangerous ingredients and pose serious health risks, urging purchases only from licensed pharmacies.
- On Wednesday, Health Canada issued a public advisory warning people not to buy or use unauthorized GLP-1 drugs including semaglutide, the active ingredient in Ozempic and Wegovy, saying do not buy or use unauthorized products.
- Rising demand for weight‑loss GLP-1s has led to growing interest in these products, prompting people to seek unauthorized options sold by retailers and online sellers in Canada.
- Unauthorized products pose multiple safety hazards, including incorrect ingredients and contamination, while websites and social media advertisers misuse Health Canada logos to mislead consumers, Health Canada said.
- Health Canada is coordinating with the Canada Border Services Agency to block shipments, actively monitoring the market, seizing products, and advising purchases only from licensed pharmacies with an eight‑digit DIN.
- To protect patients, the regulator urges reporting of suspected counterfeits and side effects, noting genuine GLP-1 therapies list serious risks; Health Canada advises people who have used unauthorized GLP-1 products to consult health‑care professionals and report concerns to its reporting system.
12 Articles
12 Articles
Health Canada Warns About Risks of Purchasing Fake Semaglutide Drugs
Health Canada has issued a warning to Canadians about counterfeit weight loss medications being sold in stores and online. In the safety advisory, the health agency says fake versions of semaglutide and tirzepatide have been found online and in stores. The authorized version of the drugs are sold under brand names such as Ozempic, Wegovy, and Zepbound. Health Canada says the counterfeit medications can pose serious health risks to those who take…
Beware 'fauxzempic': Health Canada warns people to watch for fake GLP
Health Canada is warning people not to buy or use fake or unauthorized versions of GLP-1 drugs such as semaglutide, the active ingredient in Ozempic and Wegovy. The health agency says it has found retailers in Canada selling unauthorized GLP-1 products — sometimes referred to as "fauxzempic" — both in stores and online.
The Hamilton Spectator
Growing popularity of GLP-1 drugs, such as Ozempic, prompts warning from Health Canada
The popularity of GLP-1 drugs in Canada has prompted a warning from Health Canada about the risks of unauthorized and counterfeit drugs.
Coverage Details
Bias Distribution
- 70% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
